Yungjin Pharm. Co., Ltd. (KRX:003520)
South Korea · Delayed Price · Currency is KRW 2,040.00
0.00 (0.00%)
At close: Sep 8, 2025
Yungjin Pharm. Market Cap
Yungjin Pharm. has a market cap or net worth of 373.10 billion as of September 8, 2025. Its market cap has decreased by -18.24% in one year.
Market Cap
373.10B
Enterprise Value
n/a
Revenue
158.79B
Ranking
n/a
PE Ratio
38.14
Stock Price
2,040.00
Market Cap Chart
Since April 16, 1993, Yungjin Pharm.'s market cap has increased from 61.80B to 373.10B, an increase of 503.69%. That is a compound annual growth rate of 5.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 373.10B | 2.62% |
| Dec 30, 2024 | 363.59B | -6.45% |
| Dec 28, 2023 | 388.65B | -34.62% |
| Dec 29, 2022 | 594.40B | -38.56% |
| Dec 30, 2021 | 967.50B | -34.20% |
| Dec 30, 2020 | 1,470.46B | 21.27% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.31T |
| Celltrion | 37.23T |
| ALTEOGEN | 25.41T |
| Yuhan | 8,902.27B |
| SK Biopharmaceuticals | 8,551.81B |
| Peptron | 7,070.75B |
| PharmaResearch | 6,545.48B |
| ABL Bio | 5,621.23B |